SDI Stock

SDI FCF/Debt

Delisted·Jul 7, 2026

The Free Cash Flow to Debt Ratio of SDI (SDI.AX) as of Aug 6, 2026 is 59.26 %. In the previous year, Free Cash Flow to Debt Ratio was 16.26 % — a change of 264.38% (higher).

FCF/Debt

59.26 %

YoY

264.38%

Last updated:

Free Cash Flow to Debt Ratio of SDI is 2026 59.26 % . Free Cash Flow to Debt Ratio of SDI was 2025 16.26 % . It decreases by 264.38% higher compared to the previous year.
Access this data via the Eulerpool API

SDI Stock analysis

What does SDI do? SDI Ltd is a British company specializing in the development and manufacture of scientific and medical devices. The company was founded by John Poulter in 1952 and is headquartered in Basingstoke, Hampshire. The history of SDI Ltd began with the development of scientific measuring devices, particularly instruments for measuring optical signals. Over the years, the company has specialized in the development of devices for medical diagnostics and therapy. SDI Ltd now operates in various areas. One of its main business fields is microbiology and infection prevention. The company offers a wide range of products including test systems for infectious diseases such as HIV, Hepatitis B and C, tuberculosis, and malaria. Another business field of SDI Ltd is the development of devices for the diagnosis of cancer and other diseases. The company offers both instruments for tissue sampling as well as automated diagnostic systems. SDI Ltd is also active in medical technology and offers a wide range of products, from simple instruments like thermal thermometers to complex surgical instruments and implants. In addition to medical diagnostics and therapy, SDI Ltd is also active in the field of analytical technology. The company offers instruments for chemical analysis, environmental monitoring, and food sampling. The business model of SDI Ltd is based on the development and manufacture of high-quality and reliable devices for scientific, medical, and industrial use. The company relies on close collaboration with customers and partners to provide innovative solutions for the challenges of modern science and medicine. An important part of SDI Ltd's business model is research and development. The company invests a significant portion of its revenue in the development of new products and technologies to always offer its customers the latest and best solutions. Overall, SDI Ltd has established itself as a leading company in the field of scientific and medical devices. The company has a long history of successful product developments and is known for its high quality, reliability, and innovation. With its wide range of products and its commitment to research and development, SDI Ltd is well-equipped to continue playing an important role in science and medicine in the future. SDI is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SDI stock

Free Cash Flow to Debt Ratio of SDI is 59.26 % in 2026.

Free Cash Flow to Debt Ratio of SDI changed from 16.26 % to 59.26 %, representing a 264.38% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio SDI since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's SDI with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — SDI

All Key Metrics — SDI